Clinical Evaluation of Bendazac Lysine Salt in the Treatment of Senile and Adult Cataract.
- Author:
Young Soo JO
1
;
Sang Moo LEE
;
Sang Ha KIM
Author Information
1. Department of Ophthalmology, Kyung Pook National University, School of Medicine, Taegu, Korea.
- Publication Type:Original Article
- MeSH:
Adult*;
Cataract*;
Humans;
Lysine*;
Visual Acuity
- From:Journal of the Korean Ophthalmological Society
1986;27(5):763-767
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
The lysine salt of Bendazac was orally administered(500mg daily) to 18 patients(29 eyes) suffering from senile or adult cataract, for the range of 2 to 6 months. The visual acuity tests and the evaluation of variations of lens opacities by means of slit lamp biomicroscopy showed some improvement in 3 eyes(10.3%) whereas no changes occurred in 24 eyes(82.8%) and aggravation in 2 eyes(6.9%). Although visual improvement was seen in 3 eyes, this was statistically not significant(p>0.1). Group treated with Bendazac lysine salt was not compared with the placebo group.
